KLOW

KLOW is a four-peptide research blend consisting of BPC-157, TB-500, KPV, and GHK-Cu. It is supplied for laboratory investigation of coordinated signaling pathways involving nitric oxide modulation, cytoskeletal remodeling, NF-κB–associated transcriptional activity, and redox-related molecular markers. All applications are limited to non-clinical research use only.

$105

Buy 2, Get GHK-Cu Free

What It Is	KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 sequence), KPV, and GHK-Cu. The blend is supplied for experimental investigation of coordinated peptide signaling pathways in controlled laboratory systems.
What It’s Derived From	KLOW incorporates four independently characterized peptide sequences: BPC-157 – derived from a partial sequence of a gastric protein known as body protection compound (BPC).TB-500 – corresponds to the 43–amino–acid sequence motif of thymosin beta-4, an actin-binding peptide identified in eukaryotic cells.KPV (Lys-Pro-Val) – derived from the C-terminal region of alpha-melanocyte–stimulating hormone (α-MSH).GHK-Cu – formed from the naturally occurring tripeptide Gly-His-Lys complexed with copper(II), identified in human plasma and other biological fluids.
What Research Focuses On	Experimental models evaluate this peptide combination in studies examining nitric oxide–associated signaling, actin-cytoskeletal dynamics, NF-κB–related transcriptional pathways, extracellular matrix–associated molecular markers, and peptide–metal interaction mechanisms under defined preclinical conditions.

This product is indented for research purposes only. All product information is for educational purposes only. This product is not a drug, food or cosmetic.